More than 3,500 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in New Orleans from April 15-18 for AMCP 2024, the industry’s largest and most impactful annual meeting. Attendees connected with like-minded professionals, discussed the important trends impacting their work, and expanded their horizons through cutting-edge education sessions.
On Feb. 29, 2024, the Centers for Medicare and Medicaid Services (CMS) issued The Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents. AMCP submitted comments in response to this Model Documents on April 29, 2024.
Christina Barrington, PharmD, vice president and chief pharmacy officer at Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, has been sworn in as president of the Board of Directors for the Academy of Managed Care Pharmacy (AMCP) for 2024-2025.
The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI), a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy. Incorporating AMCP’s existing Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), the ARI will expand the scope of research opportunities for AMCP, thereby helping to advance the larger goal of improving public health in the United States.
AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship and selects Daria Sinclair of Howard University to be the first Health Disparities Research Intern.
On Feb. 15, 2024, the Centers for Medicare and Medicaid Services (CMS) issued the Medicare Prescription Payment Plan: Draft Part Two Guidance and a Fact Sheet to provide guidance on education and outreach requirements for the Medicare Prescription Payment Plan (M3P), which was established by the Inflation Reduction Act (IRA). AMCP submitted comments in response to this Guidance on March 15, 2024.
AMCP has chosen Iulia Opran, a PharmD/MS candidate, as its 2024–2025 Executive Fellow in Health Care Association Leadership. Her diverse pharmacy background and passion for managed care make her a valuable addition to the program, which begins on July 1, 2024.
In a March 5, 2024 press release, the Department of Health & Human Services (HHS) expressed intent to issue guidance to encourage Medicare Advantage (MA) and Part D plans to relax or remove prior authorization requirements and other utilization management strategies. On March 6, 2024, CMS issued a memo encouraging MA and Part D plans to relax or remove prior authorization requirements in response to the Change Healthcare cyberatack. AMCP sent a letter in response to this guidance on March 8, 2024.